Cue Biopharma (CUE) Return on Assets (2018 - 2025)

Cue Biopharma has disclosed Return on Assets across 8 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Assets for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.0% for Q4 2025 at Cue Biopharma, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q3 2025 to a low of 0.01% in Q3 2024.
• The 5-year median for Return on Assets is 0.01% (2022), against an average of 0.01%.
• Across the five-year window, Return on Assets changed 0 bps in 2021 and grew 1 bps in 2024, its largest moves.
• Cue Biopharma's Return on Assets stood at 0.01% in 2021, then dropped by 17 bps to 0.01% in 2022, then dropped by 20 bps to 0.01% in 2023, then jumped by 76 bps to 0.0% in 2024, then gained by 29 bps to 0.0% in 2025.
• The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.